abberior
Karsten Bahlmann, PhD, MBA, is the Chief Scientific Officer at Abberior Instruments GmbH since 2016, bringing extensive experience in scientific research and innovation management. Previously, Karsten served as Innovator in Residence at Siemens Healthcare, where contributions included developing the Digital Health portfolio for Siemens Technology to Business unit. Educational credentials include an MBA from the MIT Sloan School of Management, a PhD in Physics/Biophysics from the Max Planck Institute for Biophysical Chemistry, and an M.S. in Physics from Heidelberg University. As a co-founder and CSO of TissueVision, Karsten helped advance photonics-based pre-clinical tissue imaging platforms, significantly impacting drug development and academic research. Early career experience includes a postdoctoral associate position at the Massachusetts Institute of Technology.
This person is not in any offices
abberior
abberior is a company like no other. Founded as a spin-off from Prof. Stefan W. Hell’s laboratory, we have become a world-leading innovator and manufacturer of cutting-edge superresolution and confocal microscopes. We are growing and will continue to grow but we will always maintain the pioneering spirit of Prof. Hell’s lab. We do things differently. We do things better. As the only manufacturer of superresolution microscopes, abberior develops and sells proprietary fluorescent dyes and labels ideally suited for superresolution microscopies, such as STED, MINFLUX, GSD, PALM, STORM, GSDIM, SIM, and RESOLFT. They also give outstanding results in confocal and epifluorescence microscopy as well as in single-molecule applications. Our mission is to become the leading supplier of fluorescent labels in superresolution microscopy.